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INTRODUCTION
Interstitial lung disease (ILD) is defined as a specific form
of chronic fibrosing interstitial pneumonitis limited to the
lung. It is a rare, chronic, progressive, usually fatal intersti-
tial lung disorder (1-3). In children, interstitial pneumonitis
(IP) presents with a wide spectrum of histologic abnormali-
ties that usually do not fit the classification for IP used in
the adult population (4). IP is a group of very rare diseases in
childhood (5).
The familial form can be described, as IP occurred in at
least two members of a family (2, 3, 6). The proportion of
familial ILD is unknown, and a genetic basis of it is estimat-
ed to be 0.5-2.2% of cases (6). In approximately half of the
clinically unaffected family members, it is transmitted as an
autosomal dominant trait with reduced penetrance but auto-
somal recessive pattern is not excluded (3, 6-8).
Although the etiology of the majority of ILDs is still un-
known, there is increasing understanding of the cellular and
cytokine interactions associated with inflammation and fibro-
sis. Host susceptibility, genetic factors and environmental
cofactors may influence clinical expression of each disease (9).
The inflammatory process of ILD begins with an initial injury
to the alveolar and interstitial structures (alveolitis), which
is followed by a stage of tissue repair and variable degrees of
fibrosis, and an alveolar infiltrate with variable amounts of
proteinaceous material (4, 10). The accumulation of proteina-
ceous material in the alveolar space is a characteristic finding
in lung diseases associated with surfactant system abnormal-
ities (4). There are reports that mutations in surfactant pro-
tein B (SP-B) and surfactant protein C (SP-C) are associated
with familial usual interstitial pneumonitis in adults and with
cellular nonspecific interstitial pneumonitis (NSIP) in children
(6). Recently, a mutation in the gene encoding the hydropho-
bic, lung-specific SP-C was discovered in association with a
decrease in the level of SP-C in familial ILDs (4, 10, 11).
Here we report a very young Korean girl with symptoms
and radiological findings of ILD similar to those of her older
sister who died from this disease. Open lung biopsy showed
that the patient had NSIP. Chest computed tomography (CT)
scans of both sisters were compared and the findings, etiolo-
gy and treatment of this disease are discussed.
CASE REPORT
A 21 month-old girl was brought to Asan Medical Center
suffering fever, cough and tachypnea for 4 months. Abnor-
mal lung findings were first noted by a chest radiography
taken due to fever when she was 8 months old. No further
evaluation was performed at that time. The symptoms of the
patient at 21 months of age were the same as those that her
sister had shown at age 4 yr. 
Physical examination of the patient revealed tachypnea at
rest (beyond 60/min) and chest retraction without rales or
wheezing, but no digital clubbing. On arrival at the hospi-
tal, the Denver symptom score (12) of ILD gave a value of 2
points meaning the patient showed respiratory symptoms
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Familial Interstitial Lung Disease in Two Young Korean Sisters
Most of the interstitial lung diseases are rare, chronic, progressive and fatal disor-
ders, especially in familial form. The etiology of the majority of interstitial lung dis-
ease is still unknown. Host susceptibility, genetic and environmental factors may
influence clinical expression of each disease. With familial interstitial lung diseases,
mutations of surfactant protein B and surfactant protein C or other additional genetic
mechanisms (e.g. mutation of the gene for ATP-binding cassette transporter A3)
could be associated. We found a 21 month-old girl with respiratory symptoms, abnor-
mal radiographic findings and abnormal open lung biopsy findings compatible with
nonspecific interstitial pneumonitis that is similar to those of her older sister died
from this disease. We performed genetic studies of the patient and her parents, but
we could not find any mutation in our case. High-dose intravenous methylpredni-
solone and oral hydroxychloroquine were administered and she is still alive without
progression during 21 months of follow-up.
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but oxygen saturation was normal in room air under all con-
ditions. Blood, urine, sputum and stool studies revealed no
evidence of acute viral or bacterial infection. Neither virus
(adenovirus, influenza virus, parainfluenza virus, respiratory
syncytial virus, cytomegalovirus) nor bacteria was found in
bronchoalveolar lavage fluid. The chest radiography showed
a dense hazy area at the central region of both lungs and blunt-
ing on the left costophrenic angle. Chest CT (Fig. 1A) demon-
strated diffuse fibrosis on the medial portion of both lung
fields and subpleural consolidation along both lateral pleura.
Based on the similar findings from chest CT (Fig. 1B), the
sister of the patient had been diagnosed with uncharacter-
ized ILD, and died 5 months after diagnosis. Surgical open
lung biopsy (Fig. 2) was performed at 22 months of age. A
diagnosis of NSIP was made based on the findings of diffuse,
uniform thickening of the interstitium with lymphoplasma-
cytic infiltration and collagen fibrosis. Some alveoli contain
accumulation of intra-alveolar macrophages, while some alve-
oli had hyperplastic type II alveolar pneumocytes. Genetic
studies were performed with the lung biopsy specimens and
peripheral blood mononuclear cells. These revealed no iden-
tifiable mutation in the genes encoding surfactant proteins.
Examination of peripheral blood cells from the patient’s par-
ents also showed no evidence of mutations in these genes.
The patient was treated with high-dose intravenous methyl-
prednisolone (30 mg/kg/day, 3 doses every other day, monthly)
and oral hydroxychloroquine (daily).
During treatment, tachypnea and dyspnea on exertion were
Fig. 2. Interstitial pneumonia with lymphoplasmacytic infiltration and variable amount of collagen fibrosis resulted in the thickening of the
interstitium. Most alveoli also show variable amount of intra-alveolar macrophage accumulation and hyperplasia of the alveolar pneumo-
cytes. (A) Hematoxylin-eosin stain, ×100, (B) Masson’s trichrome stain, ×100.
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Fig. 1. Computed tomography (CT) scans of the patient (A) and the patient’s sister (B), showing diffuse fibrosis and subpleural consolida-
tions in both lungs.
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still evident and the Denver symptom score was 2 points at
follow-up. Follow-up high resolution CT (HRCT) showed
that there was no further disease progression after 21 months. 
DISCUSSION
There have been previous reports of familial ILD, and infants
with this disease can become symptomatic in the first 6 weeks
of life (1). Such patients have tachypnea and respiratory dis-
tress with grunting, intercostal and subcostal retraction, and
cyanosis. The mortality rate is high, especially in children
younger than 1 yr (1). The ILD of unknown origin which was
developed in the present patient’s sister progressed quickly
and she died at 4 yr of age, 5 months after she had been diag-
nosed. 
Risk factors for ILD are virus (adenovirus, Epstein-Barr
virus, influenza virus, cytomegalovirus), mycoplasma or other
infectious agents, drugs, chronic aspiration, environmental
factors like metal dust and wood dust, and genetic predispo-
sition (5, 13). Given that investigations on the etiology of
the present patient ruled out any environmental or infectious
causes, we examined genetic factors. There were analyses of
candidate loci near the human leukocyte antigen (HLA) region
of chromosome 6 to suggest a genetic basis for ILD in famil-
ial cases (6). In addition, an association has been established
between interstitial pulmonary fibrosis and  1-antitrypsin
inhibition alleles present on chromosome 14 (2). Recently,
several investigators reported that multiple heterozygous
mutations in the surfactant protein C gene were associated
with ILD (10). Triggers such as infection or toxins may con-
tribute to the wide diversity in clinical presentation of surfac-
tant protein C gene-associated pulmonary fibrosis (6). In our
case, the pathological findings were compatible with NSIP
but we did not find a surfactant protein gene mutation in
lung biopsy samples or peripheral blood cells from the patient,
or in peripheral blood cells from her parents. There was a
report of fatal respiratory diseases in full-term infants with
symptoms of surfactant deficiency in whom a deficiency of
surfactant protein B was excluded. It suggested that the muta-
tion of the genes for ATP-binding cassette transporter A3
(ABCA3) that were involved in the transport of phospholipids
and sterols could be associated with unexplained surfactant
deficiency in full-term infants (14).
HRCT allows early diagnosis of ILD and commonly shows
patchy, predominantly peripheral, subpleural, bibasilar retic-
ular abnormalities (15). The extent of pulmonary infiltration
on CT is an important predictor of survival (2). We had two
similar HRCT images, one from the patient and the other
from her sister whose disease had progressed further.
The diagnosis of ILD can be confirmed by open lung biopsy
(16). The chronic pneumonitis in infancy is characterized by
interstitial thickening with mesenchymal cells rather than
inflammatory cells and by an alveolar infiltration with vari-
able amounts of proteinaceous material (10, 15). The find-
ings of the lung biopsy specimen from the present patient
also showed mild, diffuse, and uniform thickening of the
interstitium with mild fibrosis, consistent with the diagno-
sis of NSIP.
Corticosteroid administration (1, 16, 17) has been the main-
stay of therapy for ILD, and chloroquine and hydroxychloro-
quine (1, 17) have also been used successfully in the treatment
of childhood IP. However the exact mechanism of action of
this treatment is unknown. For the present patient, treatment
with methylprednisolone and hydroxychloroquine was ini-
tiated soon after ILD diagnosis due to her family history. The
Denver symptom score was used to evaluate the symptoms,
and continued use of this system indicated that patient’s dis-
ease was not progressing during 21 months of follow-up.
In summary, we have described an infant with NSIP whose
sibling died from a similar disease. The need of early diagno-
sis and treatment with corticosteroids in combination with
hydroxychloroquine for the familial ILD could be considered.
Trying to determine the etiology of the familial form of this
disease is likely to result in better treatment for these patients. 
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